S&P 500 7,408 -1.67% Nasdaq 25,138 -2.88% Dow Jones 51,712 -1.60% FTSE 100 10,675 +0.70% DAX 24,926 +0.38% Nikkei 225 64,611 +0.73% Hang Seng 24,963 +1.63% WTI Crude 89.43 +7.45% Gold 4,057 +1.17% US 10-Year Treasury Yield 4.679 +1.76% S&P 500 7,408 -1.67% Nasdaq 25,138 -2.88% Dow Jones 51,712 -1.60% FTSE 100 10,675 +0.70% DAX 24,926 +0.38% Nikkei 225 64,611 +0.73% Hang Seng 24,963 +1.63% WTI Crude 89.43 +7.45% Gold 4,057 +1.17% US 10-Year Treasury Yield 4.679 +1.76%

LATEST

Study: Argentina’s Minimum Wage Has Lost 40% of Its Value Under Milei●The Truth About Flying Your Pet Abroad: Busting Common Relocation Myths●Argentina’s Economy Contracts Again in May, Exposing Uneven Recovery●Mexico Draws More Tourists but Spending per Visitor Falls●Softbank eyeing acquisition of ETH spinout Gravis, reports suggest●The challenges companies face to launch robotaxis in Europe●Arthur Hayes, BitMEX co-founders face fraud claims over alleged ‘Insider Trading Desk’ as exchange winds down●Quote of the day by John Rogers: "All of us, all of the time, have to be on guard against groupthink"●Study: Argentina’s Minimum Wage Has Lost 40% of Its Value Under Milei●The Truth About Flying Your Pet Abroad: Busting Common Relocation Myths●Argentina’s Economy Contracts Again in May, Exposing Uneven Recovery●Mexico Draws More Tourists but Spending per Visitor Falls●Softbank eyeing acquisition of ETH spinout Gravis, reports suggest●The challenges companies face to launch robotaxis in Europe●Arthur Hayes, BitMEX co-founders face fraud claims over alleged ‘Insider Trading Desk’ as exchange winds down●Quote of the day by John Rogers: "All of us, all of the time, have to be on guard against groupthink"●

Markets

Ozempic maker takes biggest rival to court over weight-loss drug ads

TST (Full) - (Official Feed) · 1h ago

Ozempic maker takes biggest rival to court over weight-loss drug ads

Novo Nordisk, the maker of Ozempic, is suing Eli Lilly over advertisements comparing some of their biggest-selling drugs. The ads compare Lilly’s Zepbound with Novo’s Wegovy, and Novo argues they give consumers a misleading picture of how the blockbuster weight-loss drugs stack up. At the center of ...

Read the full story at TST (Full) - (Official Feed) →

More Markets

Walmart’s stock split history (& prospects) explained

TST (Full) - (Official Feed) · 52m ago

Cash Value Explained: The “Hidden” Power of Permanent Life Insurance

TST (Full) - (Official Feed) · 1h ago

Target makes another investment in key category it needs to grow

TST (Full) - (Official Feed) · 2h ago

Macy's is selling a diamond bracelet that comes in 3 colors for 75% off

TST (Full) - (Official Feed) · 5h ago